Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

NCT00333138 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: FTY720
DRUG: Placebo

Sponsor

Novartis